Detalhe da pesquisa
1.
Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM).
Eur J Cancer
; 127: 173-182, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648851
2.
Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709).
Cytotherapy
; 11(5): 631-41, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19530030
3.
Cost-utility analysis of the GC versus MVAC regimens for the treatment of locally advanced or metastatic bladder cancer.
Expert Rev Pharmacoecon Outcomes Res
; 4(1): 27-38, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19807333